S&P 500 Futures
(0.10%) 5 332.75 points
Dow Jones Futures
(0.02%) 40 146 points
Nasdaq Futures
(0.17%) 18 667 points
Oil
(0.10%) $80.14
Gas
(0.53%) $2.64
Gold
(1.13%) $2 444.60
Silver
(2.88%) $32.16
Platinum
(0.20%) $1 092.20
USD/EUR
(-0.01%) $0.920
USD/NOK
(-0.04%) $10.67
USD/GBP
(0.06%) $0.787
USD/RUB
(-0.27%) $90.72

Realtime updates for Ocumension Therapeutics [1477.HK]

Exchange: HKSE Sector: Healthcare Industry: Biotechnology
Last Updated20 May 2024 @ 03:59

-2.02% HKD 6.80

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 03:59):

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China...

Stats
Today's Volume 1.99M
Average Volume 886 360
Market Cap 4.58B
EPS HKD0 ( 2023-08-24 )
Last Dividend HKD0 ( N/A )
Next Dividend HKD0 ( N/A )
P/E -10.62
ATR14 HKD0.0150 (0.22%)

Volume Correlation

Long: -0.18 (neutral)
Short: 0.00 (neutral)
Signal:(50.5) Neutral

Ocumension Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ocumension Therapeutics Correlation - Currency/Commodity

The country flag -0.09
( neutral )
The country flag 0.48
( neutral )
The country flag 0.00
( neutral )
The country flag 0.60
( weak )
The country flag 0.00
( neutral )
The country flag 0.32
( neutral )

Ocumension Therapeutics Financials

Annual 2023
Revenue: HKD246.37M
Gross Profit: HKD144.37M (58.60 %)
EPS: HKD-0.590
FY 2023
Revenue: HKD246.37M
Gross Profit: HKD144.37M (58.60 %)
EPS: HKD-0.590
FY 2022
Revenue: HKD158.96M
Gross Profit: HKD102.92M (64.74 %)
EPS: HKD-0.640
FY 2021
Revenue: HKD56.15M
Gross Profit: HKD36.94M (65.78 %)
EPS: HKD-0.452

Financial Reports:

No articles found.

Ocumension Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ocumension Therapeutics

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators